v3.26.1
Income Taxes (Tables)
 12 Months Ended
Sep. 30, 2025
Income Taxes [Abstract]  
Schedule of Difference Between the (Expense)/Benefit for Income Taxes and Income Taxes A reconciliation of the difference between the (expense)/benefit for income taxes and income taxes at the statutory U.S. federal income tax rate is as follows (in thousands, except amounts pertaining to rate which are shown as a percentage):

 

    Years Ended
September 30,
2025		  
Federal Statutory Rate     21.00 %
Effect of:        
Change in Valuation Allowance     (22.94 )%
RTP & Deferred True-up     (0.01 )%
Change in Rate     0.07 %
State Tax Benefit (Net of Fed)     1.90 %
M&E     (0.03 )%
Liability instrument issuance costs     (0.08 )%
Others     0.31 %
Total provision effective rate     0.22 %
Schedule of Deferred Tax Assets and Liabilities

The components of deferred tax assets and liabilities are as follows (in thousands): 

 

    September 30,
2025		  
Deferred tax assets relating to:      
Net Operating loss carryforwards   $ 4,044  
Research & development tax credit carryforward     7  
174 Expenses     1,070  
Right of Use Liability     169  
Other deferred tax assets     6,843  
Total gross deferred tax assets     12,133  
Deferred tax liabilities relating to:        
Right of Use Asset     169  
Fixed Asset     18  
Other deferred tax liabilities     -  
Total Gross deferred tax liabilities     186  
Deferred assets less liabilities     11,946  
Less: valuation allowance     (11,946 )
Net deferred tax asset (liability)   $ -  
Schedule of Net Operating Loss Carryforward and Research Activities Credits The Company had the following federal net operating loss carryforward and research activities credits as of September 30, 2025 (in thousands):

 

Year incurred   Net
Operating
Loss		     Research
Activities
Credit		  
2023   $ 219       7.33  
2024     6,588       -  
2025     10,938